Home / Opium Derivatives and Expectorants / Canada
CA ATC R05FA02 · updated 2 Nov 2026
Opium Derivatives and Expectorants shortage in Canada
Is there an Opium Derivatives and Expectorants shortage in Canada?
Yes. As of 2 Nov 2026, 3 Opium Derivatives and Expectorants products are reported short in Canada, the first since 11 Apr 2014. No return date has been given. Main reason: manufacturing problem.
Also short in Norway. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PULMORPHAN (250 ml) | LABORATOIRE RIVA INC | 11 Apr 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DIMETANE EXPECTORANT DC (1 Litre) | PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC | 5 Oct 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ROBITUSSIN AC (1 L) discontinuation | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 1 Jun 2023 | not given | Other Other (Please describe in comments) |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.